Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 7:45 pm Purchase | 13D | Provectus Biopharmaceuticals, Inc. PVCT | Pershing Edward | 36,413,097 8.030% | 13,778,047 (+60.87%) | Filing History |
| 2024-08-14 7:23 pm Purchase | 13G | Provectus Biopharmaceuticals, Inc. PVCT | Morris Jeffrey Allen | 61,100,610 11.300% | 61,100,610 (New Position) | Filing History |
| 2024-07-03 7:29 pm Purchase | 13D | Provectus Biopharmaceuticals, Inc. PVCT | Pershing Edward | 22,635,050 5.170% | 22,635,050 (New Position) | Filing History |
| 2023-05-09 4:52 pm Purchase | 13G | Provectus Biopharmaceuticals, Inc. PVCT | Morris Jeffrey Allen | 58,457,470 13.900% | 1,887,570 (+3.34%) | Filing History |
| 2023-03-28 09:13 am Purchase | 13G | Provectus Biopharmaceuticals, Inc. PVCT | Morris Jeffrey Allen | 56,569,900 13.500% | 56,569,900 (New Position) | Filing History |
| 2021-06-30 5:30 pm Purchase | 13D | Provectus Biopharmaceuticals, Inc. PVCT | WACHTER ERIC PHD | 21,032,058 5.000% | 21,032,058 (New Position) | Filing History |